Notice Title

Notice of Application to Register a Trade Name Product (Notice No. MPI ACVM 60)

Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:

Trade Name: VarroxSan

Reference: P010158

Active Ingredients and Concentrations:

Oxalic acid dihydrate: 18.42%. Other Ingredients 81.58%. Total: I00.0%

Formulation Type: Impregnated strips (non-volatile, contact action)

Application method/administration route:

Sustained-release fibre strip

Use Claim:

Strips for the in-hive control of varroosis due to Varroa destructor in honeybees

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

  1. must state in full the reasons for making the submission;
  2. may state any decision sought on that application; and
  3. must be received by the director-general no later than 30 working days after the date of this notice.

Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.

The following address is:

  1. where submissions on this application are to be sent;
  2. where requests for copies of the public information relating to the application can be sent;
  3. where public information relating to the application can be viewed; and
  4. the director-general’s address for service:

ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.

MPI encourages submission by email.

The applicant’s address for service is:

Vita Europe Limited, London Street, Basingstoke, Hants RG21 7PG, United Kingdom.

Dated at Wellington this 16th day of January 2025.

SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).